|
The House Committee on Energy and Commerce
Subcommittee on Oversight and Investigations Subcommittee on Commerce, Trade, and Consumer Protection
July 24, 2003
09:30 AM
2123 Rayburn House Office Building
The National Football League would like to thank the Subcommittees for
inviting us to participate in this hearing on ephedrine. We greatly appreciate
the opportunity to share with you our thoughts and concerns on ephedrine and
related products in the athletic environment.
DEVELOPMENT OF THE NFL'S STEROID POLICY
The National Football League and NFL Players Association have long been
committed to ensuring that our sport is not tarnished by the influence of
steroids and other performance-enhancing substances. We are guided in this
respect by three principles:
-
First, these substances threaten the fairness and integrity of the athletic
competition on the playing field and could potentially distort the results of
game and League standings. Moreover, the use of certain substances by some
players without consequence might lead other players to believe that they must
use them as well in order to remain competitive. This concern arises not only
with respect to steroids, but also with respect to ephedrine and other
stimulants, which some players believe will provide a boost or "edge"
in competition.
-
Second, the League has serious concerns about the adverse health effects of
these substances on our players. There is a growing body of medical literature
linking their use to a number of physiological, psychological, orthopedic,
reproductive and other serious health problems.
-
Third, the NFL takes very seriously its role in educating and providing
guidance to young athletes and youth generally. When young athletes see players
that they admire using these substances, their desire to use such products
increases dramatically. When combined with their still-developing judgment,
young athletes face even higher risks than professional athletes. As role
models, the NFL and its players must be concerned with such unintended
consequences.
Adhering to these principles, in 1989 the NFL became the first
professional league to implement a comprehensive program of steroid testing,
discipline and education. The key provisions of our policy are:
-
Unannounced annual and random testing of all players both in and out of
season;
-
A list of more than 70 prohibited substances including anabolic steroids,
steroid precursors, growth hormones and stimulants;
-
Mandatory 4-game suspension without pay upon first violation; and
-
Strict liability for players who test positive-violations will not be excused
because a player was unaware that a product contained a banned substance.
The consistent application of these core tenets has resulted in the NFL's policy
being considered the most effective in professional sports.
EPHEDRINE POLICY
In late 1999, the League received reports from Clubs of incidents involving
the use of ephedrine. In one case, a player who had apparently used ephedrine
had a seizure that required medical intervention. Following that incident, our
medical advisory board began to review the available medical and scientific
literature on ephedrine. Based on that initial review, we issued a health
warning on ephedrine during the 2000 season and developed an educational program
to provide more information.
In July 2001, following the tragic death of one of our players, we
undertook a comprehensive review of the potential links between ephedrine use
and heat illness, which is a focus of NFL Clubs during preseason training camp
conditions. From that investigation we concluded that the risks of ephedrine
outweighed its uncertain therapeutic benefit and that swift action was needed to
protect the health and safety of our players and the competitive integrity of
NFL football.
As a result, on September 26, 2001, the NFL became the first professional
sports league to ban the use of ephedrine and other related stimulants. (A press
release announcing the ban is attached.) After implementing an extensive player
education program and resolving a number of logistical issues, we began testing
for these substances during the 2002 preseason. Players testing positive for
ephedrine are now subject to the same discipline as those testing positive for
any other banned substance.
EPHEDRINE AND DIETARY SUPPLEMENT REGULATION
As an organization that employs world-class professional athletes, the NFL is
very concerned with dietary supplements and their regulation. In our view,
athletes represent a special category of potential supplement users. Because
their success is directly correlated to physical ability and conditioning,
athletes are generally more sensitive to issues regarding health and fitness.
Unfortunately, they are also at greater risk because of the substantial pressure
to use supplements as a part of their training regimen.
Over the past decade, the number of products claiming to provide energy,
rapid recovery and dramatic weight loss has skyrocketed. Under current federal
legislation, so-called "dietary supplements" containing ephedrine and
other stimulants can be manufactured and marketed without any effective prior
research, approvals or regulation. Scientific research has shown that these
stimulants can pose significant health risks, particularly among athletes
engaged in strenuous activity. Equally important, basic safeguards such as
testing and labeling are not adequate to guarantee that a particular product
actually contains only the ingredients listed on its label.
The cornerstone of the NFL's steroid policy is that players are
responsible for what goes into their bodies. Given the deficiencies in labeling
practices, however, it has become increasingly difficult for players to
determine which "dietary supplements" are free of ephedrine and other
prohibited substances. Anecdotal evidence suggests that a significant percentage
of players who have tested positive for ephedrine did so through the inadvertent
use of a seemingly harmless "dietary supplement."
By taking decisive action, Congress can address many of the concerns
related to the use of ephedrine by its constituency. The NFL feels strongly that
governmental leadership is critical to the continued effectiveness of our
steroid policy, as well as to the health and safety of the general public.
Printer
Friendly |